Bill Text: MI HB5835 | 2023-2024 | 102nd Legislature | Introduced
Bill Title: Criminal procedure: sentencing guidelines; sentencing guidelines for illicit use of xylazine; provide for. Amends sec. 13m of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 5834'24
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced) 2024-11-13 - Referred To Second Reading [HB5835 Detail]
Download: Michigan-2023-HB5835-Introduced.html
HOUSE BILL NO. 5835
A bill to amend 1927 PA 175, entitled
"The code of criminal procedure,"
by amending section 13m (MCL 777.13m), as amended by 2016 PA 549.
the people of the state of michigan enact:
1
2
3
Sec. 13m. This chapter applies to the following felonies enumerated in chapter 333 of the Michigan Compiled Laws:
M.C.L. |
Category |
Class |
Description |
Stat Max |
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
333.7340 |
CS |
F |
Sale, distribution, or delivery of product containing ephedrine or pseudoephedrine by mail, internet, or telephone |
4 |
333.7340c(2) |
CS |
D |
Soliciting another person to purchase or obtain ephedrine or pseudoephedrine to manufacture methamphetamine |
10 |
333.7341(8) |
CS |
G |
Delivery or manufacture of imitation controlled substance |
2 |
333.7401(2)(a)(i) |
CS |
A |
Delivery or manufacture of 1,000 or more grams of certain schedule 1 or 2 controlled substances |
Life |
333.7401(2)(a)(ii) |
CS |
A |
Delivery or manufacture of 450 or more but less than 1,000 grams of certain schedule 1 or 2 controlled substances |
30 |
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
333.7401(2)(a)(iii) |
CS |
B |
Delivery or manufacture of 50 or more but less than 450 grams of certain schedule 1 or 2 controlled substances |
20 |
333.7401(2)(a)(iv) |
CS |
D |
Delivery or manufacture of less than 50 grams of certain schedule 1 or 2 controlled substances |
20 |
333.7401(2)(b)(i) |
CS |
B |
Delivery or manufacture of methamphetamine or 3, 4-methylenedioxymethamphetamine |
20 |
333.7401(2)(b)(ii) |
CS |
E |
Delivery or manufacture of certain schedule 1, 2, or 3 controlled substances |
7 |
333.7401(2)(c) |
CS |
F |
Delivery or manufacture of schedule 4 controlled substance |
4 |
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
333.7401(2)(d)(i) |
CS |
C |
Delivery or manufacture of 45 or more kilograms of marihuana or synthetic equivalents of marihuana |
15 |
333.7401(2)(d)(ii) |
CS |
D |
Delivery or manufacture of 5 or more but less than 45 kilograms of marihuana or synthetic equivalents of marihuana |
7 |
333.7401(2)(d)(iii) |
CS |
F |
Delivery or manufacture of less than 5 kilograms or 20 plants of marihuana or synthetic equivalents of marihuana |
4 |
333.7401(2)(e) |
CS |
G |
Delivery or manufacture of schedule 5 controlled substance |
2 |
333.7401(2)(f) |
CS |
D |
Delivery or manufacture of a prescription form or counterfeit prescription form |
7 |
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
333.7401(2)(g) |
CS |
E |
Delivery or manufacture of xylazine for illicit use |
5 |
333.7401a |
Person |
B |
Delivering a controlled substance or GBL with intent to commit criminal sexual conduct |
20 |
333.7401b(3)(a) |
CS |
E |
Delivery or manufacture of GBL |
7 |
333.7401b(3)(b) |
CS |
G |
Possession of GBL |
2 |
333.7401c(2)(a) |
CS |
D |
Operating or maintaining controlled substance laboratory |
10 |
333.7401c(2)(b) |
CS |
B |
Operating or maintaining controlled substance laboratory in presence of minor |
20 |
333.7401c(2)(c) |
CS |
B |
Operating or maintaining controlled substance laboratory involving hazardous waste |
20 |
333.7401c(2)(d) |
CS |
B |
Operating or maintaining controlled substance laboratory near certain places |
20 |
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
333.7401c(2)(e) |
CS |
A |
Operating or maintaining controlled substance laboratory involving firearm or other harmful device |
25 |
333.7401c(2)(f) |
CS |
B |
Operating or maintaining controlled substance laboratory involving methamphetamine |
20 |
333.7402(2)(a) |
CS |
D |
Delivery or manufacture of certain counterfeit controlled substances |
10 |
333.7402(2)(b) |
CS |
E |
Delivery or manufacture of schedule 1, 2, or 3 counterfeit controlled substance |
5 |
333.7402(2)(c) |
CS |
F |
Delivery or manufacture of counterfeit schedule 4 controlled substance |
4 |
333.7402(2)(d) |
CS |
G |
Delivery or manufacture of counterfeit schedule 5 controlled substance |
2 |
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
333.7402(2)(e) |
CS |
C |
Delivery or manufacture of controlled substance analogue |
15 |
333.7403(2)(a)(i) |
CS |
A |
Possession of 1,000 or more grams of certain schedule 1 or 2 controlled substances |
Life |
333.7403(2)(a)(ii) |
CS |
A |
Possession of 450 or more but less than 1,000 grams of certain schedule 1 or 2 controlled substances |
30 |
333.7403(2)(a)(iii) |
CS |
B |
Possession of 50 or more but less than 450 grams of certain schedule 1 or 2 controlled substances |
20 |
333.7403(2)(a)(iv) |
CS |
G |
Possession of 25 or more but less than 50 grams of certain schedule 1 or 2 controlled substances |
4 |
333.7403(2)(a)(v) |
CS |
G |
Possession of less than 25 grams of certain schedule 1 or 2 controlled substances |
4 |
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
333.7403(2)(b)(i) |
CS |
D |
Possession of methamphetamine or 3, 4-methylenedioxymethamphetamine |
10 |
333.7403(2)(b)(ii) |
CS |
G |
Possession of certain schedule 1, 2, 3, or 4 controlled substances or controlled substances analogue |
2 |
333.7403(2)(f) |
CS |
E |
Possession of xylazine for illicit use |
5 |
333.7403a 333.7403a(4)(a) |
CS |
F |
Fraudulently obtaining controlled substance or prescription for controlled substance |
4 |
333.7403a(4)(b) |
CS |
E |
Fraudulently obtaining xylazine for illicit use |
5 |
333.7405(1)(a) |
CS |
G |
Controlled substance violations by licensee |
2 |
333.7405(1)(b) |
CS |
G |
Manufacturing or distribution violations by licensee |
2 |
333.7405(1)(c) |
CS |
G |
Refusing lawful inspection |
2 |
333.7405(1)(d) |
CS |
G |
Maintaining drug house |
2 |
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
333.7405(1)(e) |
CS |
G |
Unlawfully dispensing out-of-state prescription |
2 |
333.7407(1)(a) |
CS |
G |
Controlled substance violations by licensee |
4 |
333.7407(1)(b) |
CS |
G |
Use of fictitious, revoked, or suspended license number |
4 |
333.7407(1)(c) |
CS |
G |
Obtaining controlled substance by fraud |
4 |
333.7407(1)(d) |
CS |
G |
False reports under controlled substance article |
4 |
333.7407(1)(e) |
CS |
G |
Possession of counterfeiting implements |
4 |
333.7407(1)(f) |
CS |
F |
Disclosing or obtaining prescription informationPossession of a counterfeit prescription form |
4 |
333.7407(1)(g) |
CS |
F |
Possession of counterfeit prescription form |
4 |
333.7407(2) |
CS |
G |
Refusing to furnish records under controlled substance article |
4 |
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
333.7410a |
CS |
G |
Controlled substance offense or offense involving GBL in or near a park |
2 |
333.7417 |
CS |
F |
Sell or offer to sell named product producing same or similar effect as scheduled ingredient |
4 |
333.7455(1)(a) |
CS |
E |
Sell or offer to sell certain objects for the illicit use of xylazine |
5 |
Enacting section 1. This amendatory act does not take effect unless Senate Bill No.____ or House Bill No. 5834 (request no. 05394'24) of the 102nd Legislature is enacted into law.